Cyclopropyl derivatives as NK3 receptor antagonists

Details for Australian Patent Application No. 2004265020 (hide)

International Classifications

Event Publications

9 March 2006 PCT application entered the National Phase

PCT publication WO2005/016884 Priority application(s): WO2005/016884

27 April 2006 Amendment Made

The nature of the amendment is: Delete priority details 60/501,535 08 Sep 2003 US 2004265021 H. Lundbeck A/S The nature of the amendment is: Delete the priority details 60/496,058 18 August 2003 US and 60/520,246 14 November 2003 US 2004265022 H.Lundbeck A/S The nature of the amendment is: Delete the priority details 60/496,058 18 August 2003 US and 60/520,246 14 November 2003 US 2004265174 BF Research Institute, Inc. The nature of the amendment is: Amend the invention title to read Probe for diseases in wh

16 July 2009 Application Accepted

Published as AU-B-2004265020

5 November 2009 Corrigenda

Applications Accepted - Name Index Under the name H. Lundbeck A/S, Application No. 2004265020, under INID (31) delete 60/501,535; under INID delete the date 08.09.2003; under INID , delete US

12 November 2009 Standard Patent Sealed

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.